Becker’s Healthcare Podcast Summary

Episode: Dr. Zachary Dietch on a Landmark Liver Retransplant and Evolving Cancer Guidelines
Host: Mariah Muhammad
Release Date: July 17, 2025

Introduction

In this episode of the Becker’s Healthcare Podcast, host Mariah Muhammad engages in an insightful conversation with Dr. Zachary Dietch, a transplant surgeon at Northwestern Medicine. The discussion centers around a groundbreaking liver retransplant case involving Andrew Wagner and the evolving guidelines concerning cancer patients' eligibility for organ transplants.

Dr. Zachary Dietch’s Professional Background

Timestamp: [00:00 – 00:38]

Dr. Dietch introduces himself as a transplant surgeon specializing in liver, kidney, and pancreas transplants at Northwestern Medicine. He is also a key member of the living donor liver transplant team, highlighting his extensive experience in complex transplant procedures.

Quote:
"I perform liver, kidney and pancreas transplants. That's the bulk of my practice. I'm also part of the living donor liver transplant team."
— Dr. Zachary Dietch [00:19]

Overview of Andrew Wagner’s Liver Retransplant Case

Timestamp: [00:38 – 02:16]

Dr. Dietch delves into the unique case of Andrew Wagner, a patient who required a liver retransplant approximately 20-25 years after his initial transplant for primary sclerosis and cholangitis. Wagner's case was complicated by graft failure and a history of primary lung cancer, which had been successfully resected two years prior without metastasis.

Key Points:

• Wagner had previously undergone multiple transplant evaluations, being declined by five to six centers due to his cancer history.
• Northwestern Medicine accepted his case, providing him with a second chance at a functioning liver transplant.
• This case underscores the complexities and challenges associated with retransplantation in patients with prior cancer diagnoses.

Surgical Complexities and Team Approach

Timestamp: [02:16 – 06:36]

The discussion shifts to the surgical intricacies involved in Wagner’s retransplant. Dr. Dietch outlines the heightened challenges of redo liver transplants, such as increased scarring and complications from previous surgeries. Additionally, the presence of a prior cancer diagnosis adds another layer of complexity to the decision-making process.

Notable Quotes:

• "Any redo liver transplant is more challenging than the first due to scarring and other complications."
  — Dr. Zachary Dietch [02:40]

• "The degree of scarring and challenges in his hepatectomy were extreme, making the surgery particularly technically challenging."
  — Dr. Zachary Dietch [02:40]

To navigate these challenges, Dr. Dietch emphasizes the importance of a multidisciplinary team approach, leveraging the expertise of anesthesiologists and surgical specialists to ensure a successful outcome.

Innovative Surgical Techniques: Bypass and "Liver in a Box"

Timestamp: [04:08 – 06:36]

Dr. Dietch explains the blend of traditional and innovative techniques employed during Wagner’s surgery. Historically, veno-bypass has been used in liver transplants to reduce bleeding and simplify the hepatectomy process. Although not routinely used at Northwestern Medicine, bypass was utilized in this case to manage the complex surgical landscape.

Notable Quotes:

• "We elected to put him on bypass to help us in the hepatectomy as we encountered particularly challenging stages."
  — Dr. Zachary Dietch [04:24]

In addition to bypass, the team utilized a "liver in a box" approach, involving a perfusion pump to keep the donor liver functional outside the body. This method allowed for the use of organs from donors typically excluded from retransplants, providing the surgical team with more time to perform the hepatectomy safely.

• "Having a liver on pump really allowed us to do this successfully."
  — Dr. Zachary Dietch [04:24]

These combined techniques were pivotal in overcoming the surgical hurdles presented by Wagner’s case, ultimately leading to a successful transplant outcome.

Reevaluating Transplant Eligibility for Cancer Patients

Timestamp: [06:36 – 09:06]

A significant portion of the discussion focuses on the paradigm shift in transplant eligibility criteria for patients with a history of cancer. Traditionally, a recent cancer diagnosis has been a stringent barrier to organ transplantation. However, Northwestern Medicine is at the forefront of rethinking these guidelines, particularly for patients like Wagner who demonstrate a successful cancer remission and strong candidacy otherwise.

Key Points:

• The transplant team questions conservative and sometimes arbitrary eligibility rules concerning cancer history.
• In Wagner’s case, his stage one lung cancer was successfully resected with no evidence of disease, making him a viable candidate despite previous declines.
• The broader transplant community is gradually embracing more flexible criteria, especially for cancers with favorable outcomes post-treatment.

Notable Quotes:

• "In some circumstances, it's worth reconsidering traditional guidelines and thinking about whether evidence really supports those guidelines."
  — Dr. Zachary Dietch [06:55]

• "We are rethinking indications for transplant in the setting of cancer, as illustrated by our approach to metastatic colorectal cancer."
  — Dr. Zachary Dietch [09:06]

Dr. Dietch highlights the success of expanding transplant eligibility, noting improved long-term outcomes and survival rates for patients previously deemed ineligible due to cancer history.

Conclusion and Future Perspectives

Timestamp: [09:06 – 09:20]

Mariah Muhammad wraps up the discussion by acknowledging the depth of information provided by Dr. Dietch, emphasizing the innovative approaches and evolving guidelines that are shaping the future of transplant medicine.

Final Quote:
"This has definitely been a very informative discussion."
— Mariah Muhammad [09:06]

Dr. Dietch reciprocates the appreciation, underscoring the collaborative efforts essential for pioneering advancements in healthcare.

Takeaways

• Complexity of Redo Transplants: Retransplantation poses significant surgical challenges, especially in patients with extensive scarring and prior complications.

• Innovative Techniques: Combining traditional methods like veno-bypass with innovative approaches such as perfusion pumps can enhance surgical outcomes in high-risk procedures.

• Evolving Eligibility Criteria: There is a growing movement within the transplant community to reassess and broaden eligibility criteria for cancer patients, allowing more individuals to benefit from life-saving transplants.

• Team Collaboration: Successful outcomes in complex transplant cases are heavily reliant on the expertise and coordinated efforts of a multidisciplinary medical team.

This episode sheds light on the intricate balance between surgical innovation and evolving medical guidelines, showcasing how dedicated healthcare professionals are pushing the boundaries to improve patient outcomes.